Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Understand what constitutes a good asset allocation for beginners. Enhance your investment strategy with proven insights.
17,719 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Toll Brothers posted a strong first quarter, underscoring resilience in the luxury segment through disciplined execut...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
A sizable fund disclosed a multi-million Braze stake as the stock faced a steep drop. This article explains what the ...
Microsoft trades at a decade-low multiple as AI tools expand and Copilot adoption lags. Investors weigh the AI upside...
A famous public clash from 2013 reshaped how we think about money, risk, and accountability. This finance-forward loo...
As investors hunt for catalysts in 2026, the idea of a blockbuster stock split from Booking Holdings stands out. This...
Realty Income is set to report Q4 2025 results after the close, with investors focused on whether the company maintai...
Hedge funds are chasing a single megacap, creating crowded trades. Learn what crowdedness means, how to read the sign...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
Tech giants are forecast to spend a record $700 billion on AI data centers in 2026, signaling a durable AI buildout t...
A Texas federal judge cleared ExxonMobil to move forward with a defamation case against California AG Rob Bonta over ...